SCHEMBL221844

SCHEMBL221844

C[C](C)C(=O)NC1CCCCC1

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 5/20 0.73
SMN1; SMN2 Q16637 5/20 0.73
RAB9A P51151 4/20 0.73
MAPT P10636 3/20 0.73
MAPK1 P28482 1/20 0.59
DUSP3 P51452 1/20 0.59
PTPN5 P54829 1/20 0.59
PTPN11 Q06124 1/20 0.59
EPHX1 P07099 7/20 0.58
EPHX2 P34913 3/20 0.58
KDM4E B2RXH2 1/20 0.58
ALDH1A1 P00352 1/20 0.58
CYP3A4 P08684 1/20 0.58
HTT P42858 1/20 0.52
HPGD P15428 1/20 0.51
POLB P06746 2/20 0.50
NPSR1 Q6W5P4 1/20 0.48
MMP2 P08253 2/20 0.48
CA12 O43570 1/20 0.48
CA1 P00915 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17727554 0.87
SCHEMBL4191605 0.86 NPC1 (0.73) NPC1SMN1; SMN2RAB9AMAPTMAPK1
SCHEMBL23736058 0.85 NPC1 (1.00) NPC1SMN1; SMN2RAB9AMAPTMAPK1
SCHEMBL3076504 0.85 NPC1 (1.00) NPC1SMN1; SMN2RAB9AMAPTMAPK1
SCHEMBL8165938 0.85 NPC1 (1.00) NPC1SMN1; SMN2RAB9AMAPTMAPK1
SCHEMBL2377367 0.85 NPC1 (1.00) NPC1SMN1; SMN2RAB9AMAPTMAPK1
SCHEMBL14877484 0.83 SMN1; SMN2 (0.68) NPC1SMN1; SMN2RAB9AMAPTMAPK1
SCHEMBL585161 0.82 NPC1 (0.67) NPC1SMN1; SMN2RAB9AMAPTMAPK1
SCHEMBL6431914 0.82 NPC1 (0.67) NPC1SMN1; SMN2RAB9AMAPTMAPK1
SCHEMBL23506579 0.82 NPC1 (0.67) NPC1SMN1; SMN2RAB9AMAPTMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9340498-B2 Raft polymerisation COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESERACH ORGANISATION (AU) 2016-05-17 US claimed
WO-2023102600-A1 SYNTHESIS OF AMPHIPHILIC BLOCK COPOLYMERS AND POLYMERIC NANOFIBERS PRODUCED THEREFROM NEWSOUTH INNOVATIONS PTY LIMITED (AU) 2023-06-15 WO disclosed
EP-2389395-B1 RAFT POLYMERISATION COMMW SCIENT IND RES ORG (AU) 2017-03-29 EP disclosed
US-9340498-B2 Raft polymerisation COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESERACH ORGANISATION (AU) 2016-05-17 US disclosed
US-20120004381-A1 RAFT POLYMERISATION COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) 2012-01-05 US disclosed
EP-2389395-A1 RAFT POLYMERISATION Commonwealth Scientific and Industrial Research Organisation (AU) 2011-11-30 EP disclosed
US-20110256644-A1 MASKS FOR MICROLITHOGRAPHY AND METHODS OF MAKING AND USING SUCH MASKS MICRON TECHNOLOGY, INC. (US) 2011-10-20 US disclosed
WO-2010083569-A1 RAFT POLYMERISATION COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) 2010-07-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120004381-A1 RAFT POLYMERISATION OXGR1, FRG1, MSR1 NPC1 340/4885SMN1; SMN2 1215/4885RAB9A 3808/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.